EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Magnetic Resonance Imaging Frequency After Stereotactic Body Radiation Therapy for Spine Metastases

Hanbo Chen, Eshetu G Atenafu, K Liang Zeng, Aimee Chan, Jay Detsky, Sten Myrehaug, Hany Soliman, Chia-Lin Tseng, Arjun Sahgal, Pejman J Maralani

International Journal of Radiation Oncology*Biology*Physics · 2024-08 · 119 (5) · 1413-1421

DOI: 10.1016/j.ijrobp.2024.02.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-08. Verfasst von Hanbo Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. Electronic address: hanbo.chen@sunnybrook.ca. Hauptthemen laut MEDLINE: Spinal Neoplasms, Radiosurgery, Magnetic Resonance Imaging, Disease Progression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Stereotactic body radiation therapy (SBRT) is increasingly being used to treat spine metastases. Current post-SBRT imaging surveillance strategies in this patient population may benefit from a more data-driven and personalized approach. The objective of this study was to develop risk-stratified post-SBRT magnetic resonance imaging (MRI) surveillance strategies using quantitative methods. METHODS AND MATERIALS: Adult patients with bony spine metastases treated with SBRT between 2008 and 2021 and who had at least 2 follow-up spine MRIs were reviewed retrospectively. A recursive partitioning analysis model was developed to separate patients into different risk categories for post-SBRT progression anywhere within the spine. Imaging intervals were derived for each risk category using parametric survival regression based on multiple expected spine progression rates per scan. RESULTS: A total of 446 patients and 1039 vertebral segments were included. Cumulative incidence of spine progression was 19.2% at 1 year, 26.7% at 2 years, and 35.3% at 4 years. The internally validated risk stratification model was able to divide patients into 3 risk categories based on epidural disease, paraspinal disease, and Spinal Instability Neoplastic Score category. The 4-year risk of spine progression was 23.4%, 39.0%, and 51.8%, respectively, for the low-, intermediate-, and high-risk groups. Using an expected per-scan spine progression rate of 3.75%, the low-risk group would require follow-up scans every 6.0 months (95% CI, 4.9-7.6) and the intermediate-risk group would require surveillance every 3.1 months (95% CI, 2.6-3.7). At an expected spine progression rate of 5%, the high-risk group would require surveillance every 1.3 months (95% CI, 1.1-1.6) during the first 13.2 months after SBRT and every 5.9 months thereafter (95% CI, 2.8-12.3). CONCLUSIONS: Data-driven follow-up MRI surveillance intervals at a range of expected spine progression rates have been determined for patients at different risks of spine progression based on an internally validated, single-institution risk stratification model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal NeoplasmsRadiosurgeryMagnetic Resonance ImagingDisease ProgressionHumansMaleMiddle AgedFemaleAgedRetrospective StudiesAdultAged, 80 and overRisk Assessment

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. Electronic address: hanbo.chen@sunnybrook.ca.
  • Department of Biostatistics, University Health Network, University of Toronto, Toronto, Ontario Canada.
  • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
  • Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Zitieren

APA

Chen, H., Atenafu, E. G., Zeng, K. L., Chan, A., Detsky, J., Myrehaug, S., Soliman, H., Tseng, C. L., Sahgal, A., & Maralani, P. J. (2024). Magnetic Resonance Imaging Frequency After Stereotactic Body Radiation Therapy for Spine Metastases. International Journal of Radiation Oncology*Biology*Physics, 119(5), 1413-1421. https://doi.org/10.1016/j.ijrobp.2024.02.010

Vancouver

Chen H, Atenafu EG, Zeng KL, Chan A, Detsky J, Myrehaug S, et al. Magnetic Resonance Imaging Frequency After Stereotactic Body Radiation Therapy for Spine Metastases. International Journal of Radiation Oncology*Biology*Physics. 2024;119(5):1413-1421. doi:10.1016/j.ijrobp.2024.02.010

BibTeX
@article{Chen2024,
  author = {Chen, Hanbo and Atenafu, Eshetu G and Zeng, K Liang and Chan, Aimee and Detsky, Jay and Myrehaug, Sten and Soliman, Hany and Tseng, Chia-Lin and Sahgal, Arjun and Maralani, Pejman J},
  title = {Magnetic Resonance Imaging Frequency After Stereotactic Body Radiation Therapy for Spine Metastases},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {5},
  pages = {1413--1421},
  doi = {10.1016/j.ijrobp.2024.02.010}
}
Kostenlos starten →